Results 101 to 110 of about 32,258 (154)

Activated microglial exosomes enhance α-Synuclein internalization and accelerate neurodegeneration in lewy body dementia. [PDF]

J Nanobiotechnology
Zhang M, You T, Guo M, Zhao Y, Shen W, Wang Y, Jiang Y, Dong Q, Yu J, Cui M, Zhao Y.   +10 more
europepmc   +1 more source

Self-reporting quality of life in mild-to-moderate Alzheimer's disease and Lewy body dementia: Comparing capability and health-focused measures using response process validation. [PDF]

Soc Sci Med
Kinchin I, Conlon J, Boland E, Fitzpatrick R, Leroi I, Coast J.   +5 more
europepmc   +1 more source

A Challenging Diagnostic Process: A Case of Lewy Body Dementia in Long-Standing Schizophrenia. [PDF]

Cureus
Iqbal A, Alarayedh M, Iqbal T, Olugbuyi S, Hicks-Walsh C.   +4 more
europepmc   +1 more source

Correction: Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein. [PDF]

Mol Neurodegener
Liang J, Li R, Wong G, Huang X.
europepmc   +1 more source

Reconsidering white matter vulnerability and biomarker interpretation across Lewy body dementia subtypes. [PDF]

Alzheimers Dement
Liu S, Yang S, Sui Y.
europepmc   +1 more source

Lewy Body Dementia Research in Latin America: A Scoping Review. [PDF]

Mov Disord Clin Pract
Cano-Gutiérrez C, Salazar-Londoño S, Botero-Rodriguez F, Páez-García S, Giraldo S, Santacruz-Escudero JM, Aarsland D, Borda MG, COL‐DLB.   +8 more
europepmc   +1 more source